• MariMed (MRMD) announced the evolution of its top-selling Betty’s Eddies all-natural cannabis fruit chews brand
  • The new product line includes some new products, some improved, and some long-time favourites that remain unchanged
  • It helps deliver specific effects, including sleep, relaxation, pain relief, heightened libido, and more
  • MariMed is a multi-state cannabis operator dedicated to improving lives through its high-quality products, its actions, and its values
  • MariMed Inc. (MRMD) opened trading at C$0.99 per share

MariMed (MRMD) announced the evolution of its top-selling Betty’s Eddies all-natural cannabis fruit chews brand.

The new product line includes some new products, some improved, and some long-time favourites that remain unchanged. All will feature a new look.

Each fast-acting fruit chew is custom-formulated using full-spectrum cannabis, supporting cannabinoids, and natural herbs, vitamins, and supplements. It helps deliver specific effects, including sleep, relaxation, pain relief, heightened libido, and more.

Betty’s Eddies fruit chew is vegan and gluten-free and handcrafted with real pieces of organic fruits and vegetables. It aims to deliver a delicious and sweet experience.

The new line-up of Betty’s Eddies fruit chews includes the following flavours, many with added benefits:

  • Bedtime Betty’s – for sleep
  • Ache Away Eddies – for pain relief
  • Take It Easy Eddies – for stress relief
  • Smashin’ Passion – for pleasure
  • Go Betty Go – for energy
  • Elderbetty – for immunity
  • Betty Good Times – for anytime

The evolution of Betty’s Eddies fruit chews addresses the needs of today’s cannabis consumers. According to industry research, consumers use cannabis edibles to achieve specific benefits. The top three benefits are: to sleep better, relax, and relieve pain.

MariMed is a multi-state cannabis operator dedicated to improving lives through its high-quality products, actions, and its values.

MariMed Inc. (MRMD) opened trading at C$0.99 per share.


More From The Market Online

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.

The Market Online’s Weekly Cannabis Report – April 12, 2024

Canada’s cannabis stock market fluctuated this week thanks to a combination of industry-specific developments and broader market trends